{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:42:48Z","timestamp":1790775768087,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T00:00:00Z","timestamp":1553472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"crossref","award":["DEQ20170336711"],"award-info":[{"award-number":["DEQ20170336711"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00401-019-01991-4","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T12:03:14Z","timestamp":1553515394000},"page":"173-186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":119,"title":["SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data"],"prefix":"10.1007","volume":"138","author":[{"given":"Dominique","family":"Campion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Charbonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9391-7800","authenticated-orcid":false,"given":"Ga\u00ebl","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,25]]},"reference":[{"key":"1991_CR1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000332017","volume":"32","author":"P Alexopoulos","year":"2011","unstructured":"Alexopoulos P, Guo LH, Kratzer M, Westerteicher C, Kurz A, Perneczky R (2011) Impact of SORL1 single nucleotide polymorphisms on Alzheimer\u2019s disease cerebrospinal fluid markers. Dement Geriatr Cogn Disord 32:164\u2013170. \nhttps:\/\/doi.org\/10.1159\/000332017","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1991_CR2","doi-asserted-by":"publisher","first-page":"13461","DOI":"10.1073\/pnas.0503689102","volume":"102","author":"OM Andersen","year":"2005","unstructured":"Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, Behlke J et al (2005) Neuronal sorting protein-related receptor sorLA\/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci USA 102:13461\u201313466. \nhttps:\/\/doi.org\/10.1073\/pnas.0503689102","journal-title":"Proc Natl Acad Sci USA"},{"key":"1991_CR3","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00401-016-1615-4","volume":"132","author":"OM Andersen","year":"2016","unstructured":"Andersen OM, Rudolph IM, Willnow TE (2016) Risk factor SORL1: from genetic association to functional validation in Alzheimer\u2019s disease. Acta Neuropathol 132:653\u2013665. \nhttps:\/\/doi.org\/10.1007\/s00401-016-1615-4","journal-title":"Acta Neuropathol"},{"key":"1991_CR4","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1021\/bi052120v","volume":"45","author":"OM Andersen","year":"2006","unstructured":"Andersen OM, Schmidt V, Spoelgen R, Gliemann J, Behlke J, Galatis D et al (2006) Molecular dissection of the interaction between amyloid precursor protein and its neuronal trafficking receptor SorLA\/LR11. Biochemistry 45:2618\u20132628. \nhttps:\/\/doi.org\/10.1021\/bi052120v","journal-title":"Biochemistry"},{"key":"1991_CR5","doi-asserted-by":"publisher","first-page":"220 e221","DOI":"10.1016\/j.neurobiolaging.2017.07.001","volume":"59","author":"C Bellenguez","year":"2017","unstructured":"Bellenguez C, Charbonnier C, Grenier-Boley B, Quenez O, Le Guennec K, Nicolas G et al (2017) Contribution to Alzheimer\u2019s disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls. Neurobiol Aging 59:220 e221\u2013220 e229. \nhttps:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.07.001","journal-title":"Neurobiol Aging"},{"key":"1991_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/humu.20725","volume":"29","author":"K Bettens","year":"2008","unstructured":"Bettens K, Brouwers N, Engelborghs S, De Deyn PP, Van Broeckhoven C, Sleegers K (2008) SORL1 is genetically associated with increased risk for late-onset Alzheimer disease in the Belgian population. Hum Mutat 29:769\u2013770. \nhttps:\/\/doi.org\/10.1002\/humu.20725","journal-title":"Hum Mutat"},{"key":"1991_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0112-7","author":"JC Bis","year":"2018","unstructured":"Bis JC, Jian X, Kunkle BW, Chen Y, Hamilton-Nelson KL, Bush WS et al (2018) Whole exome sequencing study identifies novel rare and common Alzheimer\u2019s-associated variants involved in immune response and transcriptional regulation. Mol Psychiatry. \nhttps:\/\/doi.org\/10.1038\/s41380-018-0112-7","journal-title":"Mol Psychiatry"},{"key":"1991_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/archneurol.2011.788","volume":"69","author":"S Caglayan","year":"2012","unstructured":"Caglayan S, Bauerfeind A, Schmidt V, Carlo AS, Prabakaran T, Hubner N et al (2012) Identification of Alzheimer disease risk genotype that predicts efficiency of SORL1 expression in the brain. Arch Neurol 69:373\u2013379. \nhttps:\/\/doi.org\/10.1001\/archneurol.2011.788","journal-title":"Arch Neurol"},{"key":"1991_CR9","doi-asserted-by":"publisher","first-page":"223ra220","DOI":"10.1126\/scitranslmed.3007747","volume":"6","author":"S Caglayan","year":"2014","unstructured":"Caglayan S, Takagi-Niidome S, Liao F, Carlo AS, Schmidt V, Burgert T et al (2014) Lysosomal sorting of amyloid-beta by the SORLA receptor is impaired by a familial Alzheimer\u2019s disease mutation. Sci Transl Med 6:223ra220. \nhttps:\/\/doi.org\/10.1126\/scitranslmed.3007747","journal-title":"Sci Transl Med"},{"key":"1991_CR10","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1212\/NXG.0000000000000116","volume":"2","author":"ML Cuccaro","year":"2016","unstructured":"Cuccaro ML, Carney RM, Zhang Y, Bohm C, Kunkle BW, Vardarajan BN et al (2016) SORL1 mutations in early- and late-onset Alzheimer disease. Neurol Genet 2:e116. \nhttps:\/\/doi.org\/10.1212\/NXG.0000000000000116","journal-title":"Neurol Genet"},{"key":"1991_CR11","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1001\/archneur.65.12.1640","volume":"65","author":"KT Cuenco","year":"2008","unstructured":"Cuenco KT, Lunetta KL, Baldwin CT, McKee AC, Guo J, Cupples LA et al (2008) Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease. Arch Neurol 65:1640\u20131648. \nhttps:\/\/doi.org\/10.1001\/archneur.65.12.1640","journal-title":"Arch Neurol"},{"key":"1991_CR12","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S1474-4422(15)00133-7","volume":"14","author":"E Cuyvers","year":"2015","unstructured":"Cuyvers E, De Roeck A, Van den Bossche T, Van Cauwenberghe C, Bettens K, Vermeulen S et al (2015) Mutations in ABCA7 in a Belgian cohort of Alzheimer\u2019s disease patients: a targeted resequencing study. Lancet Neurol 14:814\u2013822. \nhttps:\/\/doi.org\/10.1016\/S1474-4422(15)00133-7","journal-title":"Lancet Neurol"},{"key":"1991_CR13","doi-asserted-by":"publisher","first-page":"12877","DOI":"10.1523\/JNEUROSCI.4582-08.2008","volume":"28","author":"SE Dodson","year":"2008","unstructured":"Dodson SE, Andersen OM, Karmali V, Fritz JJ, Cheng D, Peng J et al (2008) Loss of LR11\/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer\u2019s disease. J Neurosci 28:12877\u201312886. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.4582-08.2008","journal-title":"J Neurosci"},{"key":"1991_CR14","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1038\/ejhg.2016.122","volume":"24","author":"MV Fernandez","year":"2016","unstructured":"Fernandez MV, Black K, Carrell D, Saef B, Budde J, Deming Y et al (2016) SORL1 variants across Alzheimer\u2019s disease European American cohorts. Eur J Hum Genet 24:1828\u20131830. \nhttps:\/\/doi.org\/10.1038\/ejhg.2016.122","journal-title":"Eur J Hum Genet"},{"key":"1991_CR15","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/mp.2011.52","volume":"16","author":"E Genin","year":"2011","unstructured":"Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, Combarros O et al (2011) APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry 16:903\u2013907. \nhttps:\/\/doi.org\/10.1038\/mp.2011.52","journal-title":"Mol Psychiatry"},{"key":"1991_CR16","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3233\/JAD-170590","volume":"61","author":"E Gomez-Tortosa","year":"2018","unstructured":"Gomez-Tortosa E, Ruggiero M, Sainz MJ, Villarejo-Galende A, Prieto-Jurczynska C, Venegas Perez B et al (2018) SORL1 variants in familial Alzheimer\u2019s disease. J Alzheimers Dis 61:1275\u20131281. \nhttps:\/\/doi.org\/10.3233\/JAD-170590","journal-title":"J Alzheimers Dis"},{"key":"1991_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E et al (2013) TREM2 variants in Alzheimer\u2019s disease. N Engl J Med 368:117\u2013127. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1211851","journal-title":"N Engl J Med"},{"key":"1991_CR18","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/ejhg.2017.87","volume":"25","author":"H Holstege","year":"2017","unstructured":"Holstege H, van der Lee SJ, Hulsman M, Wong TH, van Rooij JG, Weiss M et al (2017) Characterization of pathogenic SORL1 genetic variants for association with Alzheimer\u2019s disease: a clinical interpretation strategy. Eur J Hum Genet 25:973\u2013981. \nhttps:\/\/doi.org\/10.1038\/ejhg.2017.87","journal-title":"Eur J Hum Genet"},{"key":"1991_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S et al (2012) A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature 488:96\u201399. \nhttps:\/\/doi.org\/10.1038\/nature11283","journal-title":"Nature"},{"key":"1991_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J et al (2013) Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med 368:107\u2013116. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1211103","journal-title":"N Engl J Med"},{"key":"1991_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0358-2","author":"B Kunkle","year":"2019","unstructured":"Kunkle B, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC et al (2019) Meta-analysis of genetic association with diagnosed Alzheimer\u2019s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing. Nat Genet. \nhttps:\/\/doi.org\/10.1038\/s41588-019-0358-2","journal-title":"Nat Genet"},{"key":"1991_CR22","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet 45:1452\u20131458. \nhttps:\/\/doi.org\/10.1038\/ng.2802","journal-title":"Nat Genet"},{"key":"1991_CR23","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1212\/WNL.0000000000002627","volume":"86","author":"K Guennec Le","year":"2016","unstructured":"Le Guennec K, Nicolas G, Quenez O, Charbonnier C, Wallon D, Bellenguez C et al (2016) ABCA7 rare variants and Alzheimer disease risk. Neurology 86:2134\u20132137. \nhttps:\/\/doi.org\/10.1212\/WNL.0000000000002627","journal-title":"Neurology"},{"key":"1991_CR24","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3233\/JAD-170981","volume":"62","author":"K Guennec Le","year":"2018","unstructured":"Le Guennec K, Tubeuf H, Hannequin D, Wallon D, Quenez O, Rousseau S et al (2018) Biallelic loss of function of SORL1 in an early onset Alzheimer\u2019s disease patient. J Alzheimers Dis 62:821\u2013831. \nhttps:\/\/doi.org\/10.3233\/JAD-170981","journal-title":"J Alzheimers Dis"},{"key":"1991_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1001\/archneur.64.4.501","volume":"64","author":"JH Lee","year":"2007","unstructured":"Lee JH, Cheng R, Schupf N, Manly J, Lantigua R, Stern Y et al (2007) The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch Neurol 64:501\u2013506. \nhttps:\/\/doi.org\/10.1001\/archneur.64.4.501","journal-title":"Arch Neurol"},{"key":"1991_CR26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T et al (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536:285\u2013291. \nhttps:\/\/doi.org\/10.1038\/nature19057","journal-title":"Nature"},{"key":"1991_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.nbd.2007.09.001","volume":"29","author":"Y Li","year":"2008","unstructured":"Li Y, Rowland C, Catanese J, Morris J, Lovestone S, O\u2019Donovan MC et al (2008) SORL1 variants and risk of late-onset Alzheimer\u2019s disease. Neurobiol Dis 29:293\u2013296. \nhttps:\/\/doi.org\/10.1016\/j.nbd.2007.09.001","journal-title":"Neurobiol Dis"},{"key":"1991_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-160091","volume":"56","author":"E Louwersheimer","year":"2017","unstructured":"Louwersheimer E, Cohn-Hokke PE, Pijnenburg YA, Weiss MM, Sistermans EA, Rozemuller AJ et al (2017) Rare genetic variant in SORL1 may increase penetrance of Alzheimer\u2019s disease in a family with several generations of APOE-varepsilon4 homozygosity. J Alzheimers Dis 56:63\u201374. \nhttps:\/\/doi.org\/10.3233\/JAD-160091","journal-title":"J Alzheimers Dis"},{"issue":"1605","key":"1991_CR29","doi-asserted-by":"publisher","first-page":"e1613","DOI":"10.1016\/j.neurobiolaging.2014.12.007","volume":"36","author":"E Louwersheimer","year":"2015","unstructured":"Louwersheimer E, Ramirez A, Cruchaga C, Becker T, Kornhuber J, Peters O et al (2015) Influence of genetic variants in SORL1 gene on the manifestation of Alzheimer\u2019s disease. Neurobiol Aging 36(1605):e1613\u2013e1620. \nhttps:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.12.007","journal-title":"Neurobiol Aging"},{"key":"1991_CR30","doi-asserted-by":"publisher","first-page":"e58618","DOI":"10.1371\/journal.pone.0058618","volume":"8","author":"A Miyashita","year":"2013","unstructured":"Miyashita A, Koike A, Jun G, Wang LS, Takahashi S, Matsubara E et al (2013) SORL1 is genetically associated with late-onset Alzheimer\u2019s disease in Japanese, Koreans and Caucasians. PLoS One 8:e58618. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0058618","journal-title":"PLoS One"},{"key":"1991_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/ng.499","volume":"42","author":"SB Ng","year":"2010","unstructured":"Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM et al (2010) Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 42:30\u201335. \nhttps:\/\/doi.org\/10.1038\/ng.499","journal-title":"Nat Genet"},{"key":"1991_CR32","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.jalz.2018.06.3056","volume":"14","author":"G Nicolas","year":"2018","unstructured":"Nicolas G, Acuna-Hidalgo R, Keogh MJ, Quenez O, Steehouwer M, Lelieveld S et al (2018) Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer\u2019s disease. Alzheimers Dement 14:1632\u20131639. \nhttps:\/\/doi.org\/10.1016\/j.jalz.2018.06.3056","journal-title":"Alzheimers Dement"},{"key":"1991_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000452256","volume":"81","author":"G Nicolas","year":"2016","unstructured":"Nicolas G, Charbonnier C, Campion D (2016) From common to rare variants: the genetic component of Alzheimer disease. Hum Hered 81:129\u2013141. \nhttps:\/\/doi.org\/10.1159\/000452256","journal-title":"Hum Hered"},{"key":"1991_CR34","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/mp.2015.121","volume":"21","author":"G Nicolas","year":"2016","unstructured":"Nicolas G, Charbonnier C, Wallon D, Quenez O, Bellenguez C, Grenier-Boley B et al (2016) SORL1 rare variants: a major risk factor for familial early-onset Alzheimer\u2019s disease. Mol Psychiatry 21:831\u2013836. \nhttps:\/\/doi.org\/10.1038\/mp.2015.121","journal-title":"Mol Psychiatry"},{"key":"1991_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13041-018-0401-8","volume":"11","author":"Y Noda","year":"2018","unstructured":"Noda Y, Kuzuya A, Tanigawa K, Araki M, Kawai R, Ma B et al (2018) Fibronectin type III domain-containing protein 5 interacts with APP and decreases amyloid beta production in Alzheimer\u2019s disease. Mol Brain 11:61. \nhttps:\/\/doi.org\/10.1186\/s13041-018-0401-8","journal-title":"Mol Brain"},{"key":"1991_CR36","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1523\/JNEUROSCI.4946-05.2006","volume":"26","author":"K Offe","year":"2006","unstructured":"Offe K, Dodson SE, Shoemaker JT, Fritz JJ, Gearing M, Levey AI et al (2006) The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments. J Neurosci 26:1596\u20131603. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.4946-05.2006","journal-title":"J Neurosci"},{"key":"1991_CR37","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/mp.2012.15","volume":"17","author":"C Pottier","year":"2012","unstructured":"Pottier C, Hannequin D, Coutant S, Rovelet-Lecrux A, Wallon D, Rousseau S et al (2012) High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatry 17:875\u2013879. \nhttps:\/\/doi.org\/10.1038\/mp.2012.15","journal-title":"Mol Psychiatry"},{"key":"1991_CR38","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/acn3.582","volume":"5","author":"NS Raghavan","year":"2018","unstructured":"Raghavan NS, Brickman AM, Andrews H, Manly JJ, Schupf N, Lantigua R et al (2018) Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer\u2019s disease. Ann Clin Transl Neurol 5:832\u2013842. \nhttps:\/\/doi.org\/10.1002\/acn3.582","journal-title":"Ann Clin Transl Neurol"},{"key":"1991_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1001\/archneurol.2010.346","volume":"68","author":"C Reitz","year":"2011","unstructured":"Reitz C, Cheng R, Rogaeva E, Lee JH, Tokuhiro S, Zou F et al (2011) Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Arch Neurol 68:99\u2013106. \nhttps:\/\/doi.org\/10.1001\/archneurol.2010.346","journal-title":"Arch Neurol"},{"key":"1991_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. \nhttps:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"1991_CR41","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/ng1943","volume":"39","author":"E Rogaeva","year":"2007","unstructured":"Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F et al (2007) The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 39:168\u2013177. \nhttps:\/\/doi.org\/10.1038\/ng1943","journal-title":"Nat Genet"},{"key":"1991_CR42","doi-asserted-by":"publisher","first-page":"14826","DOI":"10.1074\/jbc.M710574200","volume":"283","author":"M Rohe","year":"2008","unstructured":"Rohe M, Carlo AS, Breyhan H, Sporbert A, Militz D, Schmidt V et al (2008) Sortilin-related receptor with A-type repeats (SORLA) affects the amyloid precursor protein-dependent stimulation of ERK signaling and adult neurogenesis. J Biol Chem 283:14826\u201314834. \nhttps:\/\/doi.org\/10.1074\/jbc.M710574200","journal-title":"J Biol Chem"},{"key":"1991_CR43","doi-asserted-by":"publisher","first-page":"e0150079","DOI":"10.1371\/journal.pone.0150079","volume":"11","author":"C Sassi","year":"2016","unstructured":"Sassi C, Ridge PG, Nalls MA, Gibbs R, Ding J, Lupton MK et al (2016) Influence of coding variability in APP-Abeta Metabolism genes in sporadic Alzheimer\u2019s disease. PLoS One 11:e0150079. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0150079","journal-title":"PLoS One"},{"key":"1991_CR44","doi-asserted-by":"publisher","first-page":"32956","DOI":"10.1074\/jbc.M705073200","volume":"282","author":"V Schmidt","year":"2007","unstructured":"Schmidt V, Sporbert A, Rohe M, Reimer T, Rehm A, Andersen OM et al (2007) SorLA\/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1. J Biol Chem 282:32956\u201332964. \nhttps:\/\/doi.org\/10.1074\/jbc.M705073200","journal-title":"J Biol Chem"},{"key":"1991_CR45","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00018-016-2410-z","volume":"74","author":"V Schmidt","year":"2017","unstructured":"Schmidt V, Subkhangulova A, Willnow TE (2017) Sorting receptor SORLA: cellular mechanisms and implications for disease. Cell Mol Life Sci 74:1475\u20131483. \nhttps:\/\/doi.org\/10.1007\/s00018-016-2410-z","journal-title":"Cell Mol Life Sci"},{"key":"1991_CR46","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J et al (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat Genet 49:1373\u20131384. \nhttps:\/\/doi.org\/10.1038\/ng.3916","journal-title":"Nat Genet"},{"key":"1991_CR47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ng.3246","volume":"47","author":"S Steinberg","year":"2015","unstructured":"Steinberg S, Stefansson H, Jonsson T, Johannsdottir H, Ingason A, Helgason H et al (2015) Loss-of-function variants in ABCA7 confer risk of Alzheimer\u2019s disease. Nat Genet 47:445\u2013447. \nhttps:\/\/doi.org\/10.1038\/ng.3246","journal-title":"Nat Genet"},{"key":"1991_CR48","doi-asserted-by":"publisher","first-page":"158 e157","DOI":"10.1016\/j.neurobiolaging.2017.12.002","volume":"64","author":"A Syama","year":"2018","unstructured":"Syama A, Sen S, Kota LN, Viswanath B, Purushottam M, Varghese M et al (2018) Mutation burden profile in familial Alzheimer\u2019s disease cases from India. Neurobiol Aging 64:158 e157. \nhttps:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.12.002","journal-title":"Neurobiol Aging"},{"key":"1991_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40478-017-0441-9","volume":"5","author":"H Thonberg","year":"2017","unstructured":"Thonberg H, Chiang HH, Lilius L, Forsell C, Lindstrom AK, Johansson C et al (2017) Identification and description of three families with familial Alzheimer disease that segregate variants in the SORL1 gene. Acta Neuropathol Commun 5:43. \nhttps:\/\/doi.org\/10.1186\/s40478-017-0441-9","journal-title":"Acta Neuropathol Commun"},{"key":"1991_CR50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/ana.24305","volume":"77","author":"BN Vardarajan","year":"2015","unstructured":"Vardarajan BN, Zhang Y, Lee JH, Cheng R, Bohm C, Ghani M et al (2015) Coding mutations in SORL1 and Alzheimer disease. Ann Neurol 77:215\u2013227. \nhttps:\/\/doi.org\/10.1002\/ana.24305","journal-title":"Ann Neurol"},{"key":"1991_CR51","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00401-016-1566-9","volume":"132","author":"J Verheijen","year":"2016","unstructured":"Verheijen J, Van den Bossche T, van der Zee J, Engelborghs S, Sanchez-Valle R, Llado A et al (2016) A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer\u2019s disease. Acta Neuropathol 132:213\u2013224. \nhttps:\/\/doi.org\/10.1007\/s00401-016-1566-9","journal-title":"Acta Neuropathol"},{"key":"1991_CR52","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.stem.2015.02.004","volume":"16","author":"JE Young","year":"2015","unstructured":"Young JE, Boulanger-Weill J, Williams DA, Woodruff G, Buen F, Revilla AC et al (2015) Elucidating molecular phenotypes caused by the SORL1 Alzheimer\u2019s disease genetic risk factor using human induced pluripotent stem cells. Cell Stem Cell 16:373\u2013385. \nhttps:\/\/doi.org\/10.1016\/j.stem.2015.02.004","journal-title":"Cell Stem Cell"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-01991-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-019-01991-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-01991-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:07:08Z","timestamp":1585008428000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-019-01991-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,25]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1991"],"URL":"https:\/\/doi.org\/10.1007\/s00401-019-01991-4","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,25]]},"assertion":[{"value":"31 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}